Financial Instruments and Derivative Instruments (Tables)

9 Months Ended

Sep. 29, 2024

Financial Instruments and Derivative Instruments

Schedule of fair value of financial assets and liabilities

	Fair Value Measurement at September 29, 2024 Using:
			Quoted Prices in Active		Significant Other		Significant
			Markets for Identical		Observable		Unobservable
			Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
	(in millions)
Assets
Plan asset for deferred compensation(1)	$	2.7	$	2.7	$	—	$	—
Interest rate swap(2)	$	3.7	$	—	$	3.7	$	—
Total assets	$	6.4	$	2.7	$	3.7	$	—
Liabilities
Plan liability for deferred compensation(3)	$	2.7	$	2.7	$	—	$	—
Interest rate swap(4)	$	2.0	$	—	$	2.0	$	—
Total liabilities	$	4.7	$	2.7	$	2.0	$	—

	Fair Value Measurements at December 31, 2023 Using:
			Quoted Prices in Active		Significant Other		Significant
			Markets for Identical		Observable		Unobservable
			Assets		Inputs		Inputs
	Total		(Level 1)		(Level 2)		(Level 3)
	(in millions)
Assets
Plan asset for deferred compensation(1)	$	2.3	$	2.3	$	—	$	—
Interest rate swap(2)	$	6.5	$	—	$	6.5	$	—
Total assets	$	8.8	$	2.3	$	6.5	$	—
Liabilities
Plan liability for deferred compensation(3)	$	2.3	$	2.3	$	—	$	—
Interest rate swap(4)	$	2.0	$	—	$	2.0	$	—
Designated foreign currency hedges(5)	$	0.2	$	—	$	0.2	$	—
Total liabilities	$	4.5	$	2.3	$	2.2	$	—

(1) Included on the Company’s consolidated balance sheet in other assets (other, net).

(2) As of September 29, 2024, $2.6 million classified in prepaid expenses and other current assets on the Company’s consolidated balance sheet and $1.1 million classified in other assets (other, net). As of December 31, 2023, $3.5 million classified in prepaid expenses and other current assets on the Company’s consolidated balance sheet and $3.0 million classified in other assets (other, net).

(3)Included on the Company’s consolidated balance sheet in accrued compensation and benefits.

(4) As of September 29, 2024, $1.1 million classified in accrued expenses and other liabilities on the Company’s consolidated balance sheet and $0.9 million classified in other noncurrent liabilities. As of December 31, 2023, $0.2 million classified in accrued expenses and other liabilities on the Company’s consolidated balance sheet and $1.8 million classified in other noncurrent liabilities.

(5)Included on the Company’s consolidated balance sheet in accrued expenses and other liabilities.